Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$57,829
+$32,330 QoQ
Shares Held
4,271
+0.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#289
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $750,511,239 across 12 Drug Manufacturers - General names. OGN ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
212,458 | $254,828,520 | |
| 2 | JNJ |
Johnson & Johnson
|
550,760 | $139,876,517 | |
| 3 | ABBV |
AbbVie Inc.
|
409,814 | $103,125,594 | |
| 4 | MRK |
Merck & Co., Inc.
|
565,110 | $72,616,635 | |
| 5 | AMGN |
Amgen Inc
|
138,472 | $50,143,480 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
284,053 | $35,887,256 | |
| 7 | PFE |
Pfizer Inc
|
1,303,824 | $31,396,081 | |
| 8 | AZN |
Astrazeneca PLC
|
149,538 | $28,355,395 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $57,829 | 4,271 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $25,499 | 4,257 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $30,472 | 4,250 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $46,244 | 4,330 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $41,875 | 4,326 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $68,866 | 4,625 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $67,423 | 4,519 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $86,199 | 4,506 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $95,385 | 4,608 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $93,661 | 4,982 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $71,667 | 4,970 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $1,097,256 | 63,206 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $1,347,239 | 64,740 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $1,543,688 | 65,633 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $1,855,138 | 66,421 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $1,579,453 | 67,498 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $2,306,272 | 68,334 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $2,409,715 | 68,987 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $1,705,748 | 56,018 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $1,877,522 | 57,259 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 | $1,775,142 | 58,663 | Shares | Defined | 2024-05-17 | |
| No filing history on record for this holder in this stock. | ||||||